by Stacey Johnson | Jan 8, 2016
Jakub Tolar, the University of Minnesota researcher who shared stage time with Pearl Jam’s Eddie Vedder, has been awarded $2.4 million, by the Schulze Family Foundation, to support his work creating new skin for people suffering from burns and skin diseases, such as...
by Hamideh Emrani | Jan 5, 2016
In the fourth in her series on “What drives research in the field of biomaterials?” blogger Hamideh Emrani interviews Professor Kevin E. Healy at the University of California, Berkeley. You can catch up on Hamideh’s earlier interviews here. I met Professor Kevin Healy...
by Mark Curtis | Dec 30, 2015
Welcome to your Cell Therapy Deal Review for the month of November. Astellas failed to achieve the majority share it needed to push through a takeover of Ocata Therapeutics valued at $379 million. ImmunoCellular Therapeutics announced a research agreement with MD...
by Mark Curtis | Dec 28, 2015
For those of you that missed ISCT’s recent webinar on manufacturing, needle-to-needle logistics and reimbursement, below is a brief re-cap of the key points on the reimbursement section that I provided. The presentation, including audio, should be available free on...
by Mark Curtis | Dec 10, 2015
Welcome to your Update from the Clinic for the month of November. There were a number of mid-stage clinical trials launched by cell-based immunotherapy companies this past month, furthering a robust global pipeline of CAR/TCR products. We also saw some efficacy data...
Comments